Heron Therapeutics reported $-63888000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
ALKERMES ALKS:US $ -35.9M 36.78M
Alnylam Pharmaceuticals ALNY:US $ -240.34M 18.12M
Amarin AMRN:US $ -31.56M 46.26M
Ani Pharmaceuticals ANIP:US $ -20.13M 4.01M
Anika Therapeutics ANIK:US $ -2.93M 2.86M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Eisai 4523:JP Y -12403M 26575M
Emergent Biosolutions EBS:US $ -3.7M 193M
Endo International Ordinary Shares ENDP:US $ -71.97M 490.09M
Esperion Therapeutics ESPR:US $ -56731000 8.39M
GlaxoSmithKline GSK:LN 1802M 1053M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Immunogen IMGN:US $ -24.14M 13.03M
Insmed INSM:US $ -94621000 18.36M
Ligand Pharmaceuticals LGND:US $ -15.38M 9.97M
Merk MRK:US $ 4310M 552M
Nektar Therapeutics NKTR:US $ -90.39M 55.25M
Neurocrine Biosciences NBIX:US $ 13.9M 21.2M
Pacira Pharmaceuticals PCRX:US $ 6.83M 11.96M
Regeneron Pharmaceuticals REGN:US $ 973.5M 1255.5M
Sangamo Biosciences SGMO:US $ -43.98M 6.48M
Surmodics SRDX:US $ -4.08M 1.27M
Teva Pharmaceutical Industries TEVA:US $ -955M 797M
Ultragenyx Pharmaceutical RARE:US $ -152.32M 29.86M
Veracyte VCYT:US $ -14.46M 3.93M
Vertex Pharmaceuticals VRTX:US $ 762.1M 8.01M